We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+16.35%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$13.1B
AUM Growth
+$972M
Cap. Flow
-$461M
Cap. Flow %
-3.51%
Top 10 Hldgs %
18.91%
Holding
405
New
17
Increased
84
Reduced
221
Closed
9

Top Buys

Rank Stock Value
1
MTD icon
Mettler-Toledo International
MTD
+$51.5M
2
VLTO icon
Veralto
VLTO
+$41.2M
3
LII icon
Lennox International
LII
+$38M
4
AVGO icon
Broadcom
AVGO
+$33.4M
5
NVDA icon
NVIDIA
NVDA
+$33M

Sector Composition

Rank Sector Weight
1 Technology 23.94%
2 Industrials 16.94%
3 Financials 15.08%
4 Healthcare 14.28%
5 Consumer Discretionary 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OGS icon
51
ONE Gas
OGS
$4.87B
$80.6M 0.61%
1,045,444
-40,815
-4% -$3.4M
AM icon
52
Antero Midstream
AM
$10.3B
$78.5M 0.6%
3,451,218
+19,667
+0.6% +$427K
LECO icon
53
Lincoln Electric
LECO
$13.8B
$78.5M 0.6%
295,611
-10,259
-3% -$2.68M
ALLE icon
54
Allegion
ALLE
$13.2B
$78M 0.59%
555,495
-11,297
-2% -$1.54M
BJ icon
55
BJs Wholesale Club
BJ
$12B
$77M 0.59%
882,941
-29,451
-3% -$2.7M
AXP icon
56
American Express
AXP
$219B
$75.9M 0.58%
224,471
-2,115
-0.9% -$677K
POWI icon
57
Power Integrations
POWI
$2.72B
$73.9M 0.56%
882,471
+304,866
+53% +$22M
FFIV icon
58
F5
FFIV
$23.8B
$73.8M 0.56%
177,380
+78
+0% +$27.7K
EXPD icon
59
Expeditors International
EXPD
$25.1B
$72.1M 0.55%
442,135
-10,422
-2% -$1.61M
AFG icon
60
American Financial Group
AFG
$11.9B
$71.3M 0.54%
509,809
-15,882
-3% -$2.11M
GWW icon
61
W.W. Grainger
GWW
$60B
$70.9M 0.54%
52,153
-1,503
-3% -$1.85M
IDA icon
62
Idacorp
IDA
$7.75B
$70.7M 0.54%
467,365
-12,246
-3% -$1.76M
PEP icon
63
PepsiCo
PEP
$185B
$69.6M 0.53%
514,132
-3,990
-0.8% -$597K
VLTO icon
64
Veralto
VLTO
$23.3B
$69.1M 0.53%
778,667
+473,932
+156% +$41.2M
RPM icon
65
RPM International
RPM
$12.8B
$68.2M 0.52%
613,484
-17,021
-3% -$1.78M
ACLS icon
66
Axcelis
ACLS
$3.25B
$68.1M 0.52%
359,256
-19,269
-5% -$2.86M
SYY icon
67
Sysco
SYY
$38.7B
$67.4M 0.51%
806,060
-74,887
-9% -$5.67M
CRL icon
68
Charles River Laboratories
CRL
$13.1B
$65.5M 0.5%
288,917
+3,492
+1% +$622K
WSM icon
69
Williams-Sonoma
WSM
$26.4B
$64.1M 0.49%
275,152
+43,875
+19% +$8.7M
STE icon
70
Steris
STE
$20.6B
$63.3M 0.48%
300,450
-7,378
-2% -$1.58M
UNH icon
71
UnitedHealth
UNH
$338B
$63.1M 0.48%
151,891
-1,690
-1% -$626K
PLXS icon
72
Plexus
PLXS
$6.44B
$62.5M 0.48%
208,024
-88,455
-30% -$23.1M
TXRH icon
73
Texas Roadhouse
TXRH
$11.3B
$61.2M 0.47%
316,558
+85,728
+37% +$14.6M
MGY icon
74
Magnolia Oil & Gas
MGY
$6.67B
$61M 0.46%
2,384,760
-843,146
-26% -$24.1M
PG icon
75
Procter & Gamble
PG
$339B
$59.7M 0.45%
407,243
-2,772
-0.7% -$403K

Similar funds

Boston Trust Walden's Q2 2026 Portfolio in Review

As of Q2 2026, Boston Trust Walden held 405 positions worth $13.1B, up 8% from $12.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Boston Trust Walden withdrew a net $461M in Q2 2026, closing 9 positions and reducing 221 holdings. Its most notable exit was ExxonMobil, an estimated $103M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Industrials and Financials.

Against the trend, Boston Trust Walden opened a new position in Lennox International worth $42.8M.

  • Boston Trust Walden's largest Q2 2026 buy was Lennox International: 74,694 shares worth $42.8M.
  • Boston Trust Walden added most to Mettler-Toledo International in Q2 2026, an estimated $51.5M increase.
  • Boston Trust Walden's biggest Q2 2026 reduction was Cooper Companies, cutting an estimated $56.4M.
  • Boston Trust Walden fully exited ExxonMobil in Q2 2026, selling an estimated $103M.
  • Boston Trust Walden's ten largest holdings make up 19% of its $13.1B portfolio in Q2 2026.
  • Boston Trust Walden opened 17 new positions and closed 9 in Q2 2026.
  • Boston Trust Walden's portfolio value rose 8% quarter-over-quarter to $13.1B.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.